A Trial of Magnesium Dependent Tinnitus

Completed · Phase 3 · Has a placebo group

Conditions studied: Tinnitus

In brief

The purpose of this study was to examine any potential benefit in lessening the severity of tinnitus (ringing or booming sensation in one or both ears) in subjects supplemented with magnesium (532 mg daily).

Key facts

Study ID

NCT01273883

Run by

Mayo Clinic

People needed

38

Starts

2011-07-01

Expected to finish

2013-10-01

Last updated by the study team

2015-04-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Normal Kidney function (last checked within 6 months). Serum creatinine levels 1.5 mg/dL or below for females, 2.0 mg/dL for males.
• An audiogram within the past 6 months
• Mayo Clinic patients who live in Phoenix area

You may not qualify if…

• Any participant with decreased kidney function within past 6 months, over 1.5 mg/dL for females and over 2.0 mg/dL for males.
• Current treatment with Lithium
• Tinnitus rating with 0, 1, or 2 on the 0-10 Tinnitus scale

Where it is running

• Mayo Clinic in Arizona — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.